STAT6 and neoplasm: However, in GBM, IL-13Rα2 competitively binds to IL-13, thereby inhibiting the STAT6 signaling pathway, promoting tumor cell invasion, metastasis, and proliferation, and inhibiting tumor cell apoptosis [64, 99].